Dr. Jeffrey O Cohen MD

Orkambi is an oral drug developed by Vertex Pharmaceuticals and approved by the United States Food and Drug Administration (FDA) for the treatment of cystic fibrosis (CF) in certain patient groups. It is the second drug to be approved for use in patients with CF, after Kalydeco. ...

It is clear that obesity can lead to future health complications, now including chronic obstructive pulmonary disease (COPD). It has been established that there is a link between obesity and COPD, as obesity can further complicate the symptoms of COPD.Obesity can be easily computed through BMI...

Acute respiratory distress syndrome, or ARDS, the malignant inflammation of the lungs, and develops as a response to an infection or infection. Recently, our understanding of the pathophysiology of this condition has improved a lot and has led to better medical interventions. Since this is one of...

When someone that you love has cystic fibrosis, you want more than anything to help them through the difficult times. Simply being there for them is an important first step towards providing them with the support they need. Additionally, you will have to spend a few hours in the day incorporating...

What is Symbicort?Symbicort is a combination drug used for the management of asthma and chronic obstructive pulmonary disease (COPD) symptoms. The two active ingredients of Symbicort are budesonide and formoterol. This combination helps relax the airways and makes breathing easier.Budesonide can be...

What is pleurisy?Pleurisy is the inflammation of the thin pleural membranes that line the lungs.What happens in pleurisy?A thin membrane called the pleura lines your lungs. The pleura are double-layered membranes that line your lungs as well as the inner aspect of the chest wall. Between these...